Genky Drugstores introduces 200m yen executive stock plan

Genky Drugstores announced a restricted stock compensation plan for directors, excluding audit committee and outside directors.

The company seeks shareholder approval for annual compensation of up to 200 million yen for restricted stock, additional to existing 240 million yen director compensation. The plan allows for maximum 100,000 shares annually, subject to transfer restrictions preventing executives from disposing of shares during the restriction period.